Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

CXCL12-CXCR4 Promotes Proliferation and Invasion of Pancreatic Cancer Cells

  • Shen, Bo (Department of Medical Oncology, the Affiliated Jiangsu Cancer Hospital of Nanjing Medical University & Jiangsu Institute of Cancer Research) ;
  • Zheng, Ma-Qing (School of Pharmacy, Nanjing University of Technology) ;
  • Lu, Jian-Wei (Department of Medical Oncology, the Affiliated Jiangsu Cancer Hospital of Nanjing Medical University & Jiangsu Institute of Cancer Research) ;
  • Jiang, Qian (Department of Surgical Oncology, the Affiliated Jiangsu Cancer Hospital of Nanjing Medical University & Jiangsu Institute of Cancer Research) ;
  • Wang, Tai-Hong (Department of Surgical Oncology, the Affiliated Jiangsu Cancer Hospital of Nanjing Medical University & Jiangsu Institute of Cancer Research) ;
  • Huang, Xin-En (Department of Medical Oncology, the Affiliated Jiangsu Cancer Hospital of Nanjing Medical University & Jiangsu Institute of Cancer Research)
  • Published : 2013.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: CXCL12 exerts a wide variety of chemotactic effects on cells. Evidence indicates that CXCL12, in conjunction with its receptor, CXCR4, promotes invasion and metastasis of tumor cells. Our objective was to explore whether the CXCL12-CXCR4 biological axis might influence biological behavior of pancreatic cancer cells. Methods: Miapaca-2 human pancreatic cancer cells were cultured under three different conditions: normal medium (control), medium + recombinant CXCL12 (CXCL12 group), or medium + CXCR4-inhibitor AMD3100 (AMD3100 group). RT-PCR was applied to detect mRNA expression levels of CXCL12, CXCR4, matrix metalloproteinase 2 (MMP-2), MMP-9, and human urokinase plasminogen activator (uPA). Additionally, cell proliferation and invasion were performed using CCK-8 colorimetry and transwell invasion assays, respectively. Results: CXCL12 was not expressed in Miapaca-2 cells, but CXCR4 was detected, indicating that these cells are capable of receiving signals from CXCL12. Expression of extracellular matrix-degrading enzymes MMP-2, MMP-9, and uPA was upregulated in cells exposed to exogenous CXCL12 (P<0.05). Additionally, both proliferation and invasion of pancreatic cancer cells were enhanced in the presence of exogenous CXCL12, but AMD3100 intervention effectively inhibited these processes (P<0.05). Conclusions: The CXCL12-CXCR4 biological axis plays an important role in promoting proliferation and invasion of pancreatic cancer cells.

Keywords

References

  1. Almofti A, uchida D, Begum NM, et al (2004). The clinicopathological significance of the expression of CXCR4 protein in oral squamous cell carcinoma. Int J Oncol, 25, 65-71.
  2. Balkwill F (2004). The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol, 14, 171-9. https://doi.org/10.1016/j.semcancer.2003.10.003
  3. Blanco J, Barretina J, Henson G, et al (2000). The CXCR4 antagonistAMD3100 efficiently inhibits cell-surfaceexpressed human immunodeficiency virus type 1 envelope-induced apoptosis. Antimicrob Agents Chemother, 44, 51-56. https://doi.org/10.1128/AAC.44.1.51-56.2000
  4. Chen G, Shen ZL, Wang L, et al (2013). Hsa-miR-181a-5p expression and effects on cell proliferation in gastric cancer. Asian Pac J Cancer Prev, 14, 3871-5. https://doi.org/10.7314/APJCP.2013.14.6.3871
  5. Chen GS, Yu HS, Lan CC, et al (2006). CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma. Br J Dermatol, 154, 910-8. https://doi.org/10.1111/j.1365-2133.2006.07150.x
  6. Cheng Z, Zhou S, Wang X, et al (2009). Characterization and application of two novel monoclonal antibodies against human CXCR4: cell proliferation and migration regulation for glioma cell line in vitro by CXCR4/SDF-1 alpha signal. Hybridoma (Larchmt), 28, 33-41. https://doi.org/10.1089/hyb.2008.0069
  7. Dai XZ, Yin HT, Sun LF, et al (2013). Potential therapeutic efficacy of curcumin in liver cancer. Asian Pac J Cancer Prev, 14, 3855-9. https://doi.org/10.7314/APJCP.2013.14.6.3855
  8. Demetter P, Maréchal R, Verset L, et al (2012). Molecular changes in pancreatic cancer: implications for molecular targeting therapy. Acta Gastroenterol Belg, 75, 210-4.
  9. Deng QQ, Huang XE, Ye LH, et al (2013).Phase II trial of Loubo$^{\circledR}$ (Lobaplatin) and pemetrexed for patients with metastatic breast cancer not responding to anthracycline or taxanes. Asian Pac J Cancer Prev, 14, 413-7. https://doi.org/10.7314/APJCP.2013.14.1.413
  10. Domotor A, Peidl Z, Vincze A, et al (2005). Immunohistochemical distribution of vanilloid receptor, calcitoningene related peptide and substance P in gastrointestinal mucosa of patients with different gastrointestinal disorders. Inflammopharmacology, 13, 161-77. https://doi.org/10.1163/156856005774423737
  11. Durlik M, Gardian K (2012). Metalloproteinase 2 and 9 activity in the development of pancreatic cancer. Pol Przegl Chir, 84, 377-82.
  12. Fernadis AZ, Cherla RP, Ganju RK (2003). Differential regulation of CXCR4-mediated T-cell chemotaxis and mitogen-activated protein kinase activation by the membrane tyrosine phosphatase, CD45. J Biol Chem, 278, 9536-43. https://doi.org/10.1074/jbc.M211803200
  13. Gao LL, Huang XE, Zhang Q, et al (2011). 14.A Cisplatin and vinorelbine (NP) regimen as a postoperative adjuvant chemotherapy for completely resected breast cancers in China: final results of a phase II clinical trial. Asian Pac J Cancer Prev, 12, 77-80.
  14. Ghosh S, Preet A, Groopman JE, Ganju RK (2006). Cannabinoid receptor CB2 modulates the CXCL12-CXCR4-mediated chemotaxis of T lymphocytes. Mol Immunol, 43, 2169-9. https://doi.org/10.1016/j.molimm.2006.01.005
  15. Gong P, Huang XE, Chen CY, et al (2012). Comparison on Complications of Peripherally Inserted Central Catheters by Ultrasound Guide or Conventional Method in Cancer Patients. Asian Pac J Cancer Prev, 13, 1873-5. https://doi.org/10.7314/APJCP.2012.13.5.1873
  16. Gorantla B, Asuthkar S, Rao JS, Patel J, Gondi CS (2011). Suppression of the uPAR-uPA system retards angiogenesis, invasion, and in vivo tumor development in pancreatic cancer cells. Mol Cancer Res, 9, 377-89. https://doi.org/10.1158/1541-7786.MCR-10-0452
  17. Grzesiak JJ, Smith KC, Burtom DW, Deftos LJ, Michael bouvet (2007). Integrin- mediated laminin-1 adhesion upregulates CXCR4 and IL-8 expression in pancreatic cancer cells. Surgery, 141, 804-14. https://doi.org/10.1016/j.surg.2006.12.016
  18. Gu M, Li SY, Huang XE, et al (2013). A phase II study on continuous infusional paclitaxel and 5-Fu as first-line chemotherapy for patients with advanced esophageal cancer. Asian Pac J Cancer Prev, 13, 5587-91. https://doi.org/10.7314/APJCP.2012.13.11.5587
  19. Guo L, Cui ZM, Zhang J, Huang Y (2011). Chemokine axes CXCL12-CXCR4 and CXCL16/CXCR6 correlation with lympnode metastasis in epithelial ovarian carcinoma. Chin J Cancer, 30, 336-343. https://doi.org/10.5732/cjc.010.10490
  20. Hidalgo M (2010). Pancreatic cancer. N Engl J Med, 362, 1605-17. https://doi.org/10.1056/NEJMra0901557
  21. Horuk R (2001). Chemokine receptors. Cytokine Growth Factor Rev, 12, 313-35. https://doi.org/10.1016/S1359-6101(01)00014-4
  22. Huang XE, Li CG, Li Y, et al (2011). Weekly TP regimen as a postoperative adjuvant chemotherapy for completely resected breast cancer in China: final result of a Phase II trial. Asian Pac J Cancer Prev, 12, 2797-800.
  23. Huang XE, Wei GL, Huo JG, et al (2013). Intrapleural or intraperitoneal lobaplatin for treatment of patients with malignant pleural effusion or ascites. Asian Pac J Cancer Prev, 14, 2611-4. https://doi.org/10.7314/APJCP.2013.14.4.2611
  24. Kato M, Kitayama J, Kazama S, Nagawa H (2003). Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res, 5, R144-50. https://doi.org/10.1186/bcr627
  25. Lapteva N, Yang AG, Sanders DE, Strube RW, Chen SY (2005). CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo. Cancer Gene Ther , 12, 84-9. https://doi.org/10.1038/sj.cgt.7700770
  26. Li CG, Huang XE, Li Y, et al (2011). Clinical observations on safety and efficacy of OxyContin$^{\circledR}$ administered by rectal route in treating cancer related pain. Asian Pac J Cancer Prev, 12, 2477-8.
  27. Li CG, Huang XE, Li Y, et al (2011). Phase II trial of Irinotecan plus Nedaplatin (INP) in treating patients with extensive stage small cell lung cancer. Asian Pac J Cancer Prev, 12, 487-90.
  28. Li CG, Huang XE, Xu L, et al (2012). Clinical Application of Serum Tumor Associated Material (TAM) from Non-small Cell Lung Cancer Patients. Asian Pac J Cancer Prev, 13, 301-4. https://doi.org/10.7314/APJCP.2012.13.1.301
  29. Li JK, Yu L, Shen Y, et al (2008). Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro. World J Gastroenterol, 14, 2308-13. https://doi.org/10.3748/wjg.14.2308
  30. Li Y, Yan PW, Huang XE, et al (2011). MDR1 gene C3435T polymorphism is associated with clinical outcomes in gastric cancer patients treated with postoperative adjuvant chemotherapy. Asian Pac J Cancer Prev, 12, 2405-9.
  31. Liu J, Huang XE, Tian GY, et al (2013). Phase II Study on Safety and Efficacy of Yadanzi${\circledR}$ (Javanica oil emulsion injection) Combined with Chemotherapy for Patients with Gastric Cancer. Asian Pac J Cancer Prev, 14, 2009-12. https://doi.org/10.7314/APJCP.2013.14.3.2009
  32. Liu W, Li SY, Huang XE, et al (2012). Inhibition of tumor growth in vitro by a combination of extracts from rosa roxburghii tratt and fagopyrum cymosum. Asian Pac J Cancer Prev, 13, 2409-14. https://doi.org/10.7314/APJCP.2012.13.5.2409
  33. Liu YC, Zhou SB, Gao F, et al (2013). Phase II study on breast conservative surgery plus chemo- and radiotherapy in treating Chinese patients with early staged breast cancer. Asian Pac J Cancer Prev, 14, 3747-50. https://doi.org/10.7314/APJCP.2013.14.6.3747
  34. Liu YC, Zhou SB, Gao F, et al (2013).Chemotherapy and late course three dimensional conformal radiotherapy for treatment of patients with stage III non- small cell lung cancer. Asian Pac J Cancer Prev, 14, 2663-5. https://doi.org/10.7314/APJCP.2013.14.4.2663
  35. Lu YY, Huang XE, Xu L, et al (2013). Potential predictors of sensitivity to pemetrexed as first-line chemotherapy for patients with advanced non-squamous NSCLCs. Asian Pac J Cancer Prev, 14, 2005-8. https://doi.org/10.7314/APJCP.2013.14.3.2005
  36. Lukacs NW, Berlin A, Schols D, Skerlj RT, Brideger GJ (2002). AMD3100, a CXCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity. Am J Pathol, 160, 1353-60. https://doi.org/10.1016/S0002-9440(10)62562-X
  37. Moll NM, Ransohoff RM (2010). CXCL12 and CXCR4 in bone marrow physiology. Expert Rev Hematol, 3, 315-22. https://doi.org/10.1586/ehm.10.16
  38. Muller A, Sonkoly E, Eulert C, et al (2006). Chemokine receptors in head and neck cancer: association with metastatic spread and regulation during chemotherapy. Int J Cancer, 118, 2147-57. https://doi.org/10.1002/ijc.21514
  39. Nagasawa T, Hirota S, Tachibana K, et al (1996). Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-l. Nature, 382, 635-8. https://doi.org/10.1038/382635a0
  40. Patrussi L, Baldari CT (2011). The CXCL12-CXCR4 axis as a therapeutic target in cancer and HIV-1 infection. Curr Med Chem, 18, 497-512. https://doi.org/10.2174/092986711794480159
  41. Pitcher J, Shimizu S, Burbassi S, Meucci O (2010). Disruption of neuronal CXCR4 function by opioids: preliminary evidence of ferritin heavy chain as a potential etiological agent in neuroAIDS. J Neuroimmunol, 224, 66-71. https://doi.org/10.1016/j.jneuroim.2010.05.006
  42. Ravi D, Ramadas K, Mathew BS, et al (1998). Angiogenesis during tumor progression in the oral canity is related to reduced apoptosis and high tumor cell proliferation. Oral Oncol, 34, 543-8. https://doi.org/10.1016/S1368-8375(98)00054-2
  43. Salvatore P, Pagliarulo C, Colicchio R, Napoli C (2010). CXCR4-CXCL12-dependent inflammatory network and endothelial progenitors. Curr Med Chem, 17, 3019-29. https://doi.org/10.2174/092986710791959792
  44. Scotton CJ, Wilson JL, Scott K, et al (2002). Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res, 62, 5930-8.
  45. Shu J, Li CG, Liu YC, et al (2012). Comparison of serum tumor associated material (TAM) with conventional biomarkers in cancer patients. Asian Pac J Cancer Prev, 13, 2399-403. https://doi.org/10.7314/APJCP.2012.13.5.2399
  46. Stathis A, Moore MJ (2010). Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev Clin Oncol, 7, 163-72. https://doi.org/10.1038/nrclinonc.2009.236
  47. Sun MQ, Meng AF, Huang XE, et al (2013). Comparison of psychological influence on breast cancer patients between breast-conserving surgery and modified radical mastectomy. Asian Pac J Cancer Prev, 14, 149-52. https://doi.org/10.7314/APJCP.2013.14.1.149
  48. Tashiro K, Tada H, Heilker R, et al (1993). Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science, 261, 600-3. https://doi.org/10.1126/science.8342023
  49. Terasaki M, Sugita Y, Arakawa F, et al (2011). CXCL12- CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic target. Brain Tumor Pathol, 28, 89-97. https://doi.org/10.1007/s10014-010-0013-1
  50. Wei GL, Huang XE, Huo JG, et al (2013). Phase II study on pemetrexed-based chemotherapy in treating patients with metastatic gastric cancer not responding to prior palliative chemotherapy. Asian Pac J Cancer Prev, 14, 2703-6. https://doi.org/10.7314/APJCP.2013.14.5.2703
  51. Wu X, Lee VC, Chevalier E, Hwang ST (2009). Chemokine receptors as targets for cancer therapy. Curr Pharm Des, 15, 742-57. https://doi.org/10.2174/138161209787582165
  52. Wu XY, Huang XE, You SX, et al (2013). Phase II study of pemetrexed as second or third line combined chemotherapy in patients with colorectal cancer. Asian Pac J Cancer Prev, 14, 2019-22. https://doi.org/10.7314/APJCP.2013.14.3.2019
  53. Xu HX, Huang XE, Li Y, et al (2011). A clinical study on safety and efficacy of Aidi injection combined with chemotherapy. Asian Pac J Cancer Prev, 12, 2233-6.
  54. Xu HX, Huang XE, Qian ZY, et al (2011). Clinical observation of Endostar$^{\circledR}$ combined with chemotherapy in advanced colorectal cancer patients. Asian Pac J Cancer Prev, 12, 3087-90.
  55. Xu JW, Li CG, Huang XE, et al (2011). Ubenimex capsule improves general performance and chemotherapy related toxicity in advanced gastric cancer cases. Asian Pac J Cancer Prev, 12, 985-7.
  56. Xu T, Xu ZC, Zou Q, Yu B, Huang XE (2012). P53 Arg72Pro polymorphism and bladder cancer risk--meta-analysis evidence for a link in Asians but not Caucasians. Asian Pac J Cancer Prev, 13, 2349-54. https://doi.org/10.7314/APJCP.2012.13.5.2349
  57. Xu X, Wang L, Xu HQ, Huang XE, et al (2013). Clinical comparison between paclitaxel liposome (Lipusu${\circledR}$) and paclitaxel for treatment of patients with metastatic gastric cancer. Asian Pac J Cancer Prev, 14, 2591-4. https://doi.org/10.7314/APJCP.2013.14.4.2591
  58. Yamamoto H, Itoh F, Iku S, et al (2001). Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression. J Clin Oncol, 19, 1118-27. https://doi.org/10.1200/JCO.2001.19.4.1118
  59. Yan PW, Huang XE, Yan F, et al (2011). Influence of MDR1 gene codon 3435 polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancer. Asian Pac J Cancer Prev, 12, 2291-4.
  60. Yang L, Huang XE, Zhou JN (2013). Risk assessment on anastomotic leakage after rectal cancer surgery: an analysis of 753 patients. Asian Pac J Cancer Prev, 14, 4447-53. https://doi.org/10.7314/APJCP.2013.14.7.4447
  61. Yin HT, Tian QZ, Guan L (2013).In vitro and in vivo evaluation of the antitumor efficiency of resveratrol against lung cancer. Asian Pac J Cancer Prev, 14, 1703-6. https://doi.org/10.7314/APJCP.2013.14.3.1703
  62. Yin HT, Zhang DG, Wu XL(2013). In vivo evaluation of curcumin-loaded nanoparticles in a A549 xenograft mice model. Asian Pac J Cancer Prev, 14, 409-12. https://doi.org/10.7314/APJCP.2013.14.1.409
  63. Yu DS, Huang XE, Zhou JN, et al (2012). A Comparative Study on the Value of Anal Preserving Surgery for Aged People with Low Rectal Carcinoma in Jiangsu, China. Asian Pac J Cancer Prev, 13, 2339-40. https://doi.org/10.7314/APJCP.2012.13.5.2339
  64. Zhan YP, Huang XE, Cao J et al (2012). Clinical study on safety and efficacy of Qinin${\circledR}$ (cantharidin sodium) injection combined with chemotherapy in treating patients with gastric cancer. Asian Pac J Cancer Prev, 13, 4773-6. https://doi.org/10.7314/APJCP.2012.13.9.4773
  65. Zhan YP, Huang XE, Cao J, et al (2012). Clinical safety and efficacy of Kanglaite${\circledR}$ (Coix Seed Oil) injection combined with chemotherapy in treating patients with gastric cancer. Asian Pac J Cancer Prev, 13, 5319-21. https://doi.org/10.7314/APJCP.2012.13.10.5319
  66. Zhang LQ, Huang XE, Wang J (2011). The cyclin D1 G870A polymorphism and colorectal cancer susceptibility: a metaanalysis of 20 populations. Asian Pac J Cancer Prev, 12, 81-5.
  67. Zhang XZ, Huang XE, Xu YL, et al (2012). A Phase II Study on Voriconazole in Treating Chinese Patients with Malignant Hematological Disorder and Invasive Aspergillosis. Asian Pac J Cancer Prev, 13, 2415-8. https://doi.org/10.7314/APJCP.2012.13.5.2415
  68. Zhong W, Chen W, Zhang D, et al (2012). CXCL12-CXCR4 axis plays pivotal roles in the organ-specific metastasis of pancreatic adenocarcinoma: A clinical study. Exp Ther Med, 4, 363-369. https://doi.org/10.3892/etm.2012.631

Cited by

  1. Role of MYH Polymorphisms in Sporadic Colorectal Cancer in China: A Case-control, Population-based Study vol.14, pp.11, 2013, https://doi.org/10.7314/APJCP.2013.14.11.6403
  2. Clinical Study on Safety of Cantharidin Sodium and Shenmai Injection Combined with Chemotherapy in Treating Patients with Breast Cancer Postoperatively vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5597
  3. Influence of Propofol, Isoflurane and Enflurance on Levels of Serum Interleukin-8 and Interleukin-10 in Cancer Patients vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6703
  4. Role of CXCR7 and Effects on CXCL12 in SiHa Cells and Upregulation in Cervical Squamous Cell Carcinomas in Uighur Women vol.15, pp.21, 2014, https://doi.org/10.7314/APJCP.2014.15.21.9211
  5. Anti-Proliferation Effects and Molecular Mechanisms of Action of Tetramethypyrazine on Human SGC-7901 Gastric Carcinoma Cells vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3581
  6. Malignant epithelial tumors observed in hernia sacs vol.18, pp.6, 2014, https://doi.org/10.1007/s10029-014-1283-z
  7. Activation of STAT3 is involved in malignancy mediated by CXCL12-CXCR4 signaling in human breast cancer vol.32, pp.6, 2014, https://doi.org/10.3892/or.2014.3536
  8. The influence of lentivirus-mediated CXCR4 RNA interference on hepatic metastasis of colorectal cancer vol.44, pp.6, 2014, https://doi.org/10.3892/ijo.2014.2348
  9. Metformin May Improve the Prognosis of Patients with Pancreatic Cancer vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.3937
  10. CXCR4 promotes GSK3β expression in pancreatic cancer cells via the Akt pathway vol.20, pp.3, 2015, https://doi.org/10.1007/s10147-014-0740-0
  11. The Chemokine Receptors CXCR4/CXCR7 and Their Primary Heterodimeric Ligands CXCL12 and CXCL12/High Mobility Group Box 1 in Pancreatic Cancer Growth and Development vol.44, pp.4, 2015, https://doi.org/10.1097/MPA.0000000000000298
  12. Process of hepatic metastasis from pancreatic cancer: biology with clinical significance vol.142, pp.6, 2016, https://doi.org/10.1007/s00432-015-2024-0
  13. CXCL12 expression promotes esophageal squamous cell carcinoma proliferation and worsens the prognosis vol.16, pp.1, 2016, https://doi.org/10.1186/s12885-016-2555-z
  14. NF-κB Members Left Home: NF-κB-Independent Roles in Cancer vol.5, pp.2, 2017, https://doi.org/10.3390/biomedicines5020026
  15. Mammary Gland Involution Provides a Unique Model to Study the TGF-β Cancer Paradox vol.6, pp.1, 2017, https://doi.org/10.3390/jcm6010010
  16. A transcriptomic insight into the impacts of mast cells in lung, breast, and colon cancers vol.6, pp.11, 2017, https://doi.org/10.1080/2162402X.2017.1360457
  17. Transcriptional and translational-uncoupling in regulation of the CXCL12 and its receptors CXCR4, 7 in THP-1 monocytes and macrophages pp.20504527, 2017, https://doi.org/10.1002/iid3.199
  18. Cancer-associated fibroblasts in pancreatic adenocarcinoma vol.11, pp.18, 2015, https://doi.org/10.2217/fon.15.176
  19. Inhibition of chemokine (C-X-C motif) receptor four (CXCR4) at the fetal-maternal interface during early gestation in sheep: alterations in expression of chemokines, angiogenic factors and their receptors1 vol.95, pp.3, 2017, https://doi.org/10.2527/jas.2016.1271
  20. Hypoxia and hyperoxia differentially control proliferation of rat neural crest stem cells via distinct regulatory pathways of the HIF1α-CXCR4 and TP53-TPM1 proteins vol.246, pp.3, 2017, https://doi.org/10.1002/dvdy.24481
  21. Mechanistic Insights into the Anti-angiogenic Activity of Trypanosoma cruzi Protein 21 and its Potential Impact on the Onset of Chagasic Cardiomyopathy vol.7, pp.1, 2017, https://doi.org/10.1038/srep44978
  22. Anti-fibrotic Effects of CXCR4-Targeting i-body AD-114 in Preclinical Models of Pulmonary Fibrosis vol.8, pp.1, 2018, https://doi.org/10.1038/s41598-018-20811-5
  23. Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq vol.13, pp.11, 2018, https://doi.org/10.1371/journal.pone.0206785
  24. Cell-specific pattern of berberine pleiotropic effects on different human cell lines vol.8, pp.1, 2018, https://doi.org/10.1038/s41598-018-28952-3